Literature DB >> 19816423

Expanded access rules pose quandary for drug developers.

George S Mack.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19816423     DOI： 10.1038/nbt1009-871

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients.

Authors:  Rebecca N Jerome; Terri L Edwards; Haley C Boswell; Gordon R Bernard; Paul A Harris; Jill M Pulley
Journal:  Acad Med       Date:  2016-03       Impact factor: 6.893

Review 2.  Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.

Authors:  Elena Fountzilas; Rabih Said; Apostolia M Tsimberidou
Journal:  Expert Opin Investig Drugs       Date:  2018-01-22       Impact factor: 6.206

3.  Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

Authors:  Tim K Mackey; Virginia J Schoenfeld
Journal:  BMC Med       Date:  2016-02-02       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.